Device Ortho-Knee

Velys

Payments companies reported to CMS as associated with Velys. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3.8Massociated payments (2023-2025)

2,026clinicians with associated payments

6companies reporting

By year

2023 $992K

2024 $1.0M

2025 $1.7M

Payments reported as associated with Velys, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $2.3M

Adult Reconstructive Orthopaedic Surgery $877K

Neurological Surgery $197K

Urology $94K

Orthopaedic Trauma $77K

Orthopaedic Surgery of The Spine $72K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Velys

These are the largest totals companies reported as associated with Velys. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Ryan Nunley	Saint Louis, MO	Adult Reconstructive Orthopaedic Surgery	$365,521.80
Kevin Perry	Rochester, MN	Orthopaedic Surgery	$264,792.62
Sayfe Jassim	Omaha, NE	Orthopaedic Surgery	$234,399.57
Peter Chalmers	Saint Louis, MO	Orthopaedic Surgery	$205,229.38
William Hamilton	Alexandria, VA	Adult Reconstructive Orthopaedic Surgery	$115,774.15
Zachary Post	Egg Harbor Township, NJ	Orthopaedic Surgery	$115,675.27
William Barrett	Renton, WA	Orthopaedic Surgery	$111,803.93
John Redmond	Jacksonville, FL	Adult Reconstructive Orthopaedic Surgery	$95,451.14
Savyasachi Thakkar	Washington, DC	Orthopaedic Surgery	$95,115.38
Juan Suarez	Coral Gables, FL	Urology	$94,189.90

Prescribed Velys?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.